Latest Breaking News On - உயிர் மருத்துவ ஆராய்ச்சி நெட்வொர்க்கிங் மையம் - Page 1 : comparemela.com

Intelligent detection and diagnosis of rare diseases: A case for AI

Intelligent detection and diagnosis of rare diseases: A case for AI
sciencemag.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencemag.org Daily Mail and Mail on Sunday newspapers.

Biomedical research networking center on rare diseasesMicrosoft consulting servicesCommittee for orphan medicinal productsEuropean medicines agencyDravet syndrome european federationTherapeutic action groupMicrosoft consultingOrphan medicinal productsBiomedical research networking centerRare diseasesமைக்ரோசாஃப்ட் ஆலோசனை சேவைகள்குழு க்கு ஆர்ஃபந் மருத்துவ ப்ராடக்ட்ஸ்மைக்ரோசாஃப்ட் ஆலோசனைஆர்ஃபந் மருத்துவ ப்ராடக்ட்ஸ்உயிர் மருத்துவ ஆராய்ச்சி நெட்வொர்க்கிங் மையம்ரேர் நோய்கள்

New consortium aims to accelerate development of stem cell-based therapies for Huntington s disease

New consortium aims to accelerate development of stem cell-based therapies for Huntington s disease
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.

Comunidad autonoma de catalunaEmily hendersonValidation centerUniversity of barcelonaPii sunyer biomedical research instituteBiomedical research networking center on neurodegenerative diseasesDepartment of biomedicineSpanish network of cell therapy tercelInstitute of neurosciencesHealth sciencesStem cellsBiomedical sciencesAdvanced therapiesAdvanced therapy medicinal productsStem cellBiomedical research networking center

A new international consortium to promote Stem Cell-Based Therapy for Huntington s disease

The Stem Cells for Huntington’s Disease (SC4HD) is a new international consortium created to promote advanced therapy medicinal product (ATMP) through cell transplantation studies on Huntington’s Disease. The entity, made up of twenty-eight renowned researchers from ten countries, has been officially presented in a recent publication in the J ournal of Huntington’s Disease. The main goals of SC4HD researchers are to work together with the HD community, develop criteria and guidance and address the main challenges to rapidly and safely bring potentially beneficial stem cell-based therapies to patients with this devastating disease. According to Josep M. Canals, director of Creatio and member of the steering committee of SC4HD, “there is an exciting opportunity to apply stem cell-based therapies in Huntington’s disease (HD), a devastating neurodegenerative disease that mainly affects neurons in the brain nucleus known as striatum”.

Comunidad autonoma de catalunaValidation centerUniversity of barcelonaPii sunyer biomedical research instituteBiomedical research networking center on neurodegenerative diseasesDepartment of biomedicineSpanish network of cell therapy tercelInstitute of neurosciencesHealth sciencesStem cell based therapyStem cellsBiomedical sciencesAdvanced therapiesAdvanced therapy medicinal productsStem cellBiomedical research networking center

A new international consortium to promote stem cell-based therapy for Huntington s disease

A new international consortium to promote stem cell-based therapy for Huntington s disease
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

Comunidad autonoma de catalunaValidation centerUniversity of barcelonaPii sunyer biomedical research instituteBiomedical research networking center on neurodegenerative diseasesDepartment of biomedicineSpanish network of cell therapy tercelInstitute of neurosciencesHealth sciencesStem cellsBiomedical sciencesAdvanced therapiesAdvanced therapy medicinal productsStem cellBiomedical research networking centerNeurodegenerative diseases

New therapeutic target for Huntington s treatment

E-Mail IMAGE: From left to right: Mercè Masana, Ana Gámez-Valero, Eulàlia Martí, Anna Guisado-Corcoll, Esther Pérez-Navarro and Maria Solaguren-Beascoa. view more Credit: UNIVERSITY OF BARCELONA Huntington s disease is caused by a mutation in the Huntingtin gene (HTT), which appears in adults and features motor, cognitive and psychiatric alterations. The origin of this disease has been associated with the anomalous functioning of the mutated protein: mHTT, but recent data showed the involvement of other molecular mechanisms. A new study conducted by the University of Barcelona has identified a type of ribonucleic acid (RNA) as a potential therapeutic target for the treatment of the disease. These are the small RNA, or sRNAs, molecules that do not code proteins but have important functions in the regulation of gene expression. According to the study, sRNAs would take part in the development of the disease, results that shed light on the design of new specific dr

Comunidad autonoma de catalunaActa neuropathologicaUniversity of barcelonaUniversity medical centerHealth sciences eulBiomedical research networking center on neurodegenerative diseasesInstitute of neurosciencesPii sunyer biomedical research institutePublic health networking biomedical research centreBiomedical research networking centerNeurodegenerative diseasesSunyer biomedical research instituteGenomic regulationMedicine healthPharmaceutical scienceGene therapy